{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:22:41Z","timestamp":1775182961297,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.msard.2023.104867","type":"journal-article","created":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T13:27:01Z","timestamp":1688304421000},"page":"104867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Interferon-beta exposure in-utero and the risk of infections in early childhood"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6821-4898","authenticated-orcid":false,"given":"Josefine","family":"Windfeld-Mathiasen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna Balslev","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Framke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Gade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Tr\u00e6rup","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Magyari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.104867_bib0001","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2023.104867_bib0002","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/1352458519851245","article-title":"Reproductive history of the Danish multiple sclerosis population: a register-based study","volume":"26","author":"Moberg","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104867_bib0003","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1080\/14656566.2020.1774554","article-title":"Pharmacotherapeutic considerations in women with multiple sclerosis","volume":"21","author":"Andersen","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.msard.2023.104867_bib0004","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0000000000000137","article-title":"Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis","volume":"82","author":"Karlsson","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104867_bib0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1212\/WNL.43.4.662","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI Study Group and the IFNB Multiple Sclerosis Study Group","volume":"43","author":"Paty","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104867_bib0006","unstructured":"Interferon Beta: from molecular level to therapeutic effects. - Royal Danish Library. https:\/\/soeg.kb.dk. Accessed 17 Jan 2023."},{"key":"10.1016\/j.msard.2023.104867_bib0007","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3181c97d99","article-title":"Interferon-[beta] mechanisms of action in multiple sclerosis","author":"Dhib-Jalbut","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104867_bib0008","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.aaz9330","article-title":"Prenatal development of human immunity","volume":"368","author":"Park","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.msard.2023.104867_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2006.05.071","article-title":"Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis","volume":"259","author":"Neuhaus","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2023.104867_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/14740338.2017.1311321","article-title":"Treatment of multiple sclerosis during pregnancy - safety considerations","volume":"16","author":"Th\u00f6ne","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.msard.2023.104867_bib0011","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00415-020-09762-y","article-title":"Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry","volume":"267","author":"Hellwig","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2023.104867_bib0012","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.clinthera.2010.10.006","article-title":"A meta-analysis of the efficacy and tolerability of interferon-\u03b2 in multiple sclerosis, overall and by drug and disease type","volume":"32","author":"Nikfar","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.msard.2023.104867_bib0013","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1212\/WNL.0000000000004037","article-title":"Evaluating the safety of \u03b2-interferons in MS: a series of nested case-control studies","volume":"88","author":"de Jong","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104867_bib0014","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.msard.2023.104867_bib0015","doi-asserted-by":"crossref","first-page":"e01921","DOI":"10.1002\/brb3.1921","article-title":"The Danish multiple sclerosis registry","volume":"11","author":"Magyari","year":"2021","journal-title":"Brain Behav."},{"key":"10.1016\/j.msard.2023.104867_bib0016","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.msard.2023.104867_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02260874","article-title":"Identification of patients treated with strong analgesics: an assessment of two Danish information systems with respect to epidemiological research","volume":"20","author":"S\u00f8rensen","year":"1996","journal-title":"J. Med. Syst."},{"key":"10.1016\/j.msard.2023.104867_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","article-title":"The Danish medical birth register","volume":"33","author":"Bliddal","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.msard.2023.104867_bib0019","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1403494811399957","article-title":"Danish registers on aspects of reproduction","volume":"39","author":"T\u00f8lb\u00f8ll Blenstrup","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.msard.2023.104867_bib0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.msard.2023.104867_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1403494810394715","article-title":"Danish education registers","volume":"39","author":"Jensen","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.msard.2023.104867_bib0022","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/ene.15559","article-title":"Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis","volume":"30","author":"Andersen","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2023.104867_bib0023","unstructured":"ICD-10 Version:2019. https:\/\/icd.who.int\/browse10\/2019\/en#\/K65-K67. Accessed 24 Jan 2023."},{"key":"10.1016\/j.msard.2023.104867_bib0024","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.msard.2023.104867_bib0025","series-title":"Summary of Product Characteristics","year":"2023"},{"key":"10.1016\/j.msard.2023.104867_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227120","article-title":"The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis","volume":"14","author":"Burkill","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2023.104867_bib0027","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/FAD.0000000000000050","article-title":"Adverse drug reactions: five historical scandals","volume":"324","author":"Horwitz","year":"2020","journal-title":"Advers. Drug React. Bull."},{"key":"10.1016\/j.msard.2023.104867_bib0028","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1503734","article-title":"Fish oil\u2013derived fatty acids in pregnancy and wheeze and asthma in offspring","volume":"375","author":"Bisgaard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2023.104867_bib0029","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.2019.0052","article-title":"High-dose vitamin D supplementation during pregnancy and asthma in offspring at the age of 6 years","volume":"321","author":"Brustad","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.msard.2023.104867_bib0030","first-page":"445","article-title":"The Danish prescription registries","volume":"44","author":"Gaist","year":"1997","journal-title":"Dan. Med. Bull."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T14:09:32Z","timestamp":1737641372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823003620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"alternative-id":["S2211034823003620"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104867","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-beta exposure in-utero and the risk of infections in early childhood","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104867"}}